MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Background: Cancer cells utilize a variety of mechanisms to evade immune detection and attack. Effective immune detection largely relies on the formation of an immune synapse which requires close contact between immune cells and their targets. Here, we show that MUC16, a heavily glycosylated 3-5 million Da mucin expressed on the surface of ovarian tumor cells, inhibits the formation of immune synapses between NK cells and ovarian tumor targets. Our results indicate that MUC16-mediated inhibition of immune synapse formation is an effective mechanism employed by ovarian tumors to evade immune recognition. Results: Expression of low levels of MUC16 strongly correlated with an increased number of conjugates and activating immune synapses between ovarian tumor cells and primary naïve NK cells. MUC16-knockdown ovarian tumor cells were more susceptible to lysis by primary NK cells than MUC16 expressing controls. This increased lysis was not due to differences in the expression levels of the ligands for the activating receptors DNAM-1 and NKG2D. The NK cell leukemia cell line (NKL), which does not express KIRs but are positive for DNAM-1 and NKG2D, also conjugated and lysed MUC16-knockdown cells more efficiently than MUC16 expressing controls. Tumor cells that survived the NKL challenge expressed higher levels of MUC16 indicating selective lysis of MUC16 low targets. The higher csMUC16 levels on the NKL resistant tumor cells correlated with more protection from lysis as compared to target cells that were never exposed to the effectors. Conclusion: MUC16, a carrier of the tumor marker CA125, has previously been shown to facilitate ovarian tumor metastasis and inhibits NK cell mediated lysis of tumor targets. Our data now demonstrates that MUC16 expressing ovarian cancer cells are protected from recognition by NK cells. The immune protection provided by MUC16 may lead to selective survival of ovarian cancer cells that are more efficient in metastasizing within the peritoneal cavity and also at overcoming anti-tumor innate immune responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397 · cited 1×
“Infiltration of T cells within the tumor is strongly associated with an increase in 5-year survival of ovarian cancer patients [1].”
BackgroundHLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Söderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., et al. (1998) · Nature · doi:10.1038/35869 · Cited by 2,227
Mucins in cancer: protection and control of the cell surface
Hollingsworth, M. A., & Swanson, B. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1251 · Cited by 1,807 · cited 1×
“Mucins are known to possess both adhesive and anti-adhesive properties [23].”
BackgroundTumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,592 · cited 3×
“One potential reason for differential binding between NK cells and csMUC16 low or high expressing OVCAR-3 cells could be that the csMUC16 cells were expressing higher levels of ligands of the activating receptors DNAM-1 and NKG2D that have been shown to play an important role in lysing primary ovarian cancer cells [2,…”
BackgroundHLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M., & Geraghty, D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5199 · Cited by 1,053 · cited 1×
“The signal peptideHLA-E complex is presented on the cell surface where it serves as a ligand for the inhibitory CD94/NKG2A receptor complex expressed on NK and other immune cells [42-44].”
BackgroundStructure and Function of the Cell Surface (Tethered) Mucins
Hattrup, C. L., & Gendler, S. J. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100659 · Cited by 779 · cited 1×
“Proteolytic cleavage at a site 50 amino acids upstream of the transmembrane region is hypothesized to result in shedding of the mucin from ovarian tumors [12,15,16].”
BackgroundWhy are proteins O-glycosylated?
Jentoft, N. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90014-3 · Cited by 705 · cited 2×
“It is estimated that a 28-mer peptide with Oglycan chains has a linear length of approximately 7 nm [47].”
BackgroundMolecular Cloning of the CA125 Ovarian Cancer Antigen
Yin, B. W. T., & Lloyd, K. O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103554200 · Cited by 617 · cited 10×
“Yin BW, Dnistrian A, Lloyd KO: Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene.”
BackgroundInfluentialLee, N., Goodlett, D. R., Ishitani, A., Marquardt, H., & Geraghty, D. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4951 · Cited by 505
Cell membrane-associated mucins and their adhesion-modulating property
Hilkens, J., Ligtenberg, M. J. L., Vos, H. L., & Litvinov, S. V. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90315-z · Cited by 453 · cited 2×
“In cancer, the loss of apical expression of these large molecules and the subsequent distribution over the entire cell membrane has consequences for cell-cell interactions [45].”
BackgroundGubbels, J. A., Belisle, J., Onda, M., Rancourt, C., Migneault, M., Ho, M., Bera, T. K., Connor, J., Sathyanarayana, B. K., Lee, B., et al. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-50 · Cited by 422 · cited 4×
“The csMUC16 cells surviving NK cell attack not only have the advantage of effectively evading immune attack but can also utilize csMUC16 to adhere to mesothelial cells at various sites within the peritoneal cavity [35].”
BackgroundMethodInfluentialSelf-citationThe human natural killer cell immune synapse
Davis, D. M., Chiu, I., Fassett, M., Cohen, G. B., Mandelboim, O., & Strominger, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15062 · Cited by 416 · cited 1×
“Because NK cells form immune synapses with their target cells [28-30], which involve very close cell-cell contact, the presence of an anti-adhesive molecule on the surface of ovarian tumor cells may have significant consequences for tumor cell interactions with NK cells.”
BackgroundKiller immunoglobulin-like receptors
Moretta, L., & Moretta, A. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.07.010 · Cited by 409 · cited 1×
“These KIRs are inhibitory receptors that bind to HLA class I molecules and abrogate the cytotoxic responses of NK cells [40].”
BackgroundNatural killer cell receptor signaling
Lanier, L. L. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00039-6 · Cited by 385 · cited 1×
“The strength and level of expression of these ligands determines the subsequent action of the NK cell [31].”
BackgroundLlano, M., Lee, N., Navarro, F., García, P., Albar, J. P., Geraghty, D. E., & López-Botet, M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09<2854::aid-immu2854>3.0.co;2-w · Cited by 382 · cited 1×
“The signal peptideHLA-E complex is presented on the cell surface where it serves as a ligand for the inhibitory CD94/NKG2A receptor complex expressed on NK and other immune cells [42-44].”
BackgroundThe CA 125 Gene: An Extracellular Superstructure Dominated by Repeat Sequences
O’Brien, T. J., Beard, J. B., Underwood, L. J., Dennis, R. A., Santin, A. D., & York, L. (2001) · Tumor Biology · doi:10.1159/000050638 · Cited by 300 · cited 4×
“MUC16 is a membrane spanning mucin with an average molecular weight between 3-5 million Da [12].”
BackgroundInfluentialOrange, J. S., Ramesh, N., Remold-O'Donnell, E., Sasahara, Y., Koopman, L., Byrne, M., Bonilla, F. A., Rosen, F. S., Geha, R. S., & Strominger, J. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162376099 · Cited by 295 · cited 1×
“NK-target synapse experiments were conducted according to previously established protocols [30,50,51].”
MethodTaylor, D. D., Gerçel-Taylor, Ç., Lyons, K. S., Stanson, J., & Whiteside, T. L. (2003) · PubMed · Cited by 281
The mature activating natural killer cell immunologic synapse is formed in distinct stages
Orange, J. S., Harris, K. E., Andzelm, M. M., Valter, M. M., Geha, R. S., & Strominger, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1835830100 · Cited by 260
Argüeso, P., Guzman-Aranguez, A., Mantelli, F., Cao, Z., Ricciuto, J., & Panjwani, N. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033332 · Cited by 257 · cited 1×
“MUC16 has also been shown to have a barrier function against pathogen adherence on corneal epithelial cell layers [25-27].”
BackgroundOvarian cancer antigen CA125 is encoded by the MUC16 mucin gene
Yin, B. W. T., Dnistrian, A., & Lloyd, K. O. (2002) · International Journal of Cancer · doi:10.1002/ijc.10250 · Cited by 239 · cited 2×
“This cell line was also used for the cloning of MUC16 [17].”
BackgroundMethodCharacterization of the Oligosaccharides Associated with the Human Ovarian Tumor Marker CA125
Kui Wong, N., Easton, R. L., Panico, M., Sutton-Smith, M., Morrison, J. C., Lattanzio, F. A., Morris, H. R., Clark, G. F., Dell, A., & Patankar, M. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302741200 · Cited by 238 · cited 3×
“MUC16 contains a large number of core 2 type O-glycans [14].”
BackgroundSelf-citationCarlsten, M., Björkström, N. K., Norell, H., Bryceson, Y., van Hall, T., Baumann, B. C., Hanson, M., Schedvins, K., Kiessling, R., Ljunggren, H.-G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2264 · Cited by 234 · cited 5×
“Primary cancer cells are known to express PVR and nectin, ligands for the activating NK cell receptor DNAM-1 [2,3].”
BackgroundInfluentialCharacterization of the CA 125 antigen associated with human epithelial ovarian carcinomas.
Davis, H. M., Zurawski, V. R., Bast, R. C., & Klug, T. L. (1986) · PubMed · Cited by 219
Lai, P., Rabinowich, H., Crowley‐Nowick, P. A., Bell, M. C., Mantovani, G., & Whiteside, T. L. (1996) · PubMed · Cited by 218
Functions of MUC16 in Corneal Epithelial Cells
Blalock, T. D., Spurr-Michaud, S. J., Tisdale, A. S., Heimer, S. R., Gilmore, M. S., Ramesh, V., & Gipson, I. K. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0430 · Cited by 193 · cited 2×
“RNA interference of MUC16 expression in human corneal-limbal epithelial cells resulted in increased Staphylococcus aureus adhesion on the corneal epithelial cell layer [25].”
BackgroundKrockenberger, M., Dombrowski, Y., Weidler, C., Ossadnik, M., Hönig, A., Häusler, S., Voigt, H., Becker, J. C., Leng, L., Steinle, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7338 · Cited by 179 · cited 1×
“Macrophage migration inhibitory factor (MIF) produced by ovarian tumor cells decreases the transcription and expression of the activating receptor NKG2D on NK cells thereby inhibiting their ability to recognize and lyse ovarian tumor targets [6].”
BackgroundLi, K., Mandai, M., Hamanishi, J., Matsumura, N., Suzuki, A., Yagi, H., Yamaguchi, K., Baba, T., Fujii, S., & Konishi, I. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0585-3 · Cited by 175 · cited 2×
“Other NKG2D ligands expressed by ovarian cancer cells include MICA, MICB, and Letal [7-9].”
BackgroundPotent suppression of natural killer cell response mediated by the ovarian tumor marker CA125
Patankar, M. S., JING, Y., Morrison, J. G., Belisle, J. A., Lattanzio, F. A., DENG, Y., Wong, N. K., MORRIS, H., Dell, A., & CLARK, G. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.07.030 · Cited by 149 · cited 6×
“sMUC16 is a potent inhibitor of the cytolytic ability of NK cells [11].”
BackgroundInfluentialSelf-citationKomatsu, M., Yee, L., & Carraway, K. L. (1999) · PubMed · Cited by 135
McCann, F. E., Vanherberghen, B., Eleme, K., Carlin, L. M., Newsam, R. J., Goulding, D., & Davis, D. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.2862 · Cited by 133 · cited 1×
“The NK synaptic cleft requires apposition of the effector and the target cells over a distance of 10-55 nm [48].”
BackgroundGipson, I. K., Blalock, T. D., Tisdale, A. S., Spurr-Michaud, S. J., Allcorn, S., Stavreus-Evers, A. C., & Gemzell, K. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.106.058347 · Cited by 120 · cited 1×
“csMUC16 acts as an anti-adhesive molecule in the endometrium and must be absent for successful trophoblast adherence to the endometrial wall [24].”
BackgroundBelisle, J. A., Gubbels, J. A. A., Raphael, C. A., Migneault, M., Rancourt, C., Connor, J. P., & Patankar, M. S. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02660.x · Cited by 110 · cited 5×
“Incubation of NK cells from healthy donors with sMUC16 results in a 40-70% decrease in surface expression of CD16 [10,11].”
BackgroundInfluentialSelf-citationLloyd, K. O., Yin, B. W. T., & Kudryashov, V. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970529)71:5<842::aid-ijc24>3.0.co;2-8 · Cited by 108 · cited 1×
“This cell line is therefore a good model to study the function of sMUC16 and csMUC16 [32].”
BackgroundRelease of Membrane-Associated Mucins from Ocular Surface Epithelia
Blalock, T. D., Spurr-Michaud, S. J., Tisdale, A. S., & Gipson, I. K. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1081 · Cited by 105 · cited 1×
“MUC16 has also been shown to have a barrier function against pathogen adherence on corneal epithelial cell layers [25-27].”
BackgroundThe killer's kiss: the many functions of NK cell immunological synapses
Krzewski, K., & Strominger, J. L. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.05.006 · Cited by 105 · cited 1×
“Because NK cells form immune synapses with their target cells [28-30], which involve very close cell-cell contact, the presence of an anti-adhesive molecule on the surface of ovarian tumor cells may have significant consequences for tumor cell interactions with NK cells.”
BackgroundImmune synapse formation requires ZAP-70 recruitment by ezrin and CD43 removal by moesin
Ilani, T., Khanna, C., Zhou, M., Veenstra, T. D., & Bretscher, A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200707199 · Cited by 100 · cited 1×
“CD43, which is abundantly expressed on T cells and is heavily glycosylated, is removed from the immune synapse before synapse formation between T cells and APCs [49].”
BackgroundNatural killer activity of lymphoid cells isolated from human ascitic ovarian tumors
Mantovani, A., Allavena, P., Sessa, C., Bolis, G., & Mangioni, C. (1980) · International Journal of Cancer · doi:10.1002/ijc.2910250505 · Cited by 99 · cited 2×
“Thus sMUC16 directly inhibits the natural cytotoxicity mechanism of NK cells and may also indirectly attenuate ADCC in NK cells of ovarian cancer patients.”
BackgroundBoivin, M., Lane, D. A., Piché, A., & Rancourt, C. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.08.007 · Cited by 98 · cited 4×
“This protocol for the generation of this additional cell line has been reported [37].”
BackgroundMethodInfluentialSelf-citationConejo-Garcia, J. R., Benencia, F., Courreges, M. C., Gimotty, P. A., Khang, E., Buckanovich, R. J., Frauwirth, K. A., Zhang, L., Katsaros, D., Thompson, C. B., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2194 · Cited by 80 · cited 3×
“One potential reason for differential binding between NK cells and csMUC16 low or high expressing OVCAR-3 cells could be that the csMUC16 cells were expressing higher levels of ligands of the activating receptors DNAM-1 and NKG2D that have been shown to play an important role in lysing primary ovarian cancer cells [2,…”
BackgroundTumor-derived soluble MICs impair CD3+CD56+ NKT-like cell cytotoxicity in cancer patients
WANG, H., Yang, D., XU, W., Wang, Y., Ruan, Z., Zhao, T., Han, J., & Wu, Y. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.07.001 · Cited by 59 · cited 1×
“One potential reason for differential binding between NK cells and csMUC16 low or high expressing OVCAR-3 cells could be that the csMUC16 cells were expressing higher levels of ligands of the activating receptors DNAM-1 and NKG2D that have been shown to play an important role in lysing primary ovarian cancer cells [2,…”
BackgroundStandeven, L. J., Carlin, L. M., Borszcz, P. D., Davis, D. M., & Burshtyn, D. N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5617 · Cited by 51 · cited 1×
“NK-target synapse experiments were conducted according to previously established protocols [30,50,51].”
MethodNatural killer cell‐mediated lysis of freshly isolated human tumor cells
Carlsten, M., Malmberg, K., & Ljunggren, H. (2008) · International Journal of Cancer · doi:10.1002/ijc.24082 · Cited by 39 · cited 1×
“Primary cancer cells are known to express PVR and nectin, ligands for the activating NK cell receptor DNAM-1 [2,3].”
BackgroundLotzová, E., Savary, C. A., Freedman, R. S., & Bowen, J. M. (1984) · Cancer Immunology Immunotherapy · doi:10.1007/bf00200048 · Cited by 35 · cited 2×
“Thus sMUC16 directly inhibits the natural cytotoxicity mechanism of NK cells and may also indirectly attenuate ADCC in NK cells of ovarian cancer patients.”
BackgroundVasir, B., Avigan, D., Wu, Z., Crawford, K. D., Turnquist, S., Ren, J., & Kufe, D. W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2376 · Cited by 32 · cited 2×
“This is important to note as it has previously been shown that both MUC1 and MUC4 exert anti-adhesive effects on immune synapse formation [38,39].”
BackgroundDifferential oncolytic effect of NK-enriched subsets in long-term interleukin-2 cultures.
Pr, F., & Lotzová, E. (1992) · PubMed · Cited by 13
Cited by
CA125 and Ovarian Cancer: A Comprehensive Review
Charkhchi, P., Cybulski, C., Gronwald, J., Wong, F. O., Narod, S. A., & Akbari, M. R. (2020) · Cancers · doi:10.3390/cancers12123730 · Cited by 602
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research
Kipps, E., Tan, D. S. P., & Kaye, S. B. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3432 · Cited by 562
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
Felder, M., Kapur, A., Gonzalez-Bosquet, J., Horibata, S., Heintz, J., Albrecht, R., Fass, L., Kaur, J., Hu, K., Shojaei, H., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-129 · Cited by 524
Self-citationAhmed, N., & Stenvers, K. L. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00256 · Cited by 482
Effect of tumor cells and tumor microenvironment on NK‐cell function
Vitale, M., Cantoni, C., Pietra, G., Mingari, M. C., & Moretta, L. (2014) · European Journal of Immunology · doi:10.1002/eji.201344272 · Cited by 412
Metadata
- Authors
- Gubbels, J. A., Felder, M., Horibata, S., Belisle, J. A., Kapur, A., Holden, H., Petrie, S., Migneault, M., Rancourt, C., Connor, J. P., & Patankar, M. S.
- Venue
- Molecular Cancer
- Published
- 2010-01-20
- Volume
- 9
- Issue
- 1
- Pages
- 11-11
- ISSN
- 1476-4598 (ISSN-L)
- OpenAlex
- W2162763925
- Cited by
- 209
- References
- 46
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.